0001104659-23-097802 Sample Contracts

DEFERRED EXPENSE EXCHANGE AGREEMENT

Deferred Expense Exchange Agreement • September 1st, 2023 • Nanoviricides, Inc. • Pharmaceutical preparations

• Contract Type
  Deferred Expense Exchange Agreement
• Filed
  September 1st, 2023
• Company
  Nanoviricides, Inc.
• Industry
  Pharmaceutical preparations

This DEFERRED EXPENSE EXCHANGE AGREEMENT (this “Exchange Agreement”), effective of July 19, 2023 (“Execution Date”), by and between NanoViricides, Inc., a Nevada corporation (the “Company”) and TheraCour Pharma, Inc., a Connecticut corporation (“TheraCour”) (collectively, the “Parties”).